Score of 93.18/100 qualifies for PaymentCheck Certification
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2025 - 31 Dec 2025 | 13 Apr 2026 | 25 | 96% | 1% | 3% | 11% |
| 01 Jan 2025 - 30 Jun 2025 | 13 Apr 2026 | 17 | 93% | 3% | 4% | 12% |
| 01 Jan 2025 - 30 Jun 2025 | 30 Jul 2025 | 17 | 93% | 3% | 4% | 12% |
| 01 Jul 2024 - 31 Dec 2024 | 29 Jan 2025 | 19 | 90% | 3% | 7% | 12% |
| 01 Jan 2024 - 30 Jun 2024 | 31 Jul 2024 | 39 | 48% | 28% | 25% | 39% |
| 01 Jul 2023 - 31 Dec 2023 | 29 Jan 2024 | 36 | 60% | 26% | 14% | 38% |
| 01 Jan 2023 - 30 Jun 2023 | 27 Jul 2023 | 56 | 40% | 27% | 33% | 26% |
| 01 Jul 2022 - 31 Dec 2022 | 26 Jan 2023 | 56 | 40% | 27% | 33% | 36% |
| 01 Jan 2022 - 30 Jun 2022 | 28 Jul 2022 | 57 | 33% | 34% | 33% | 46% |
| 01 Jul 2021 - 31 Dec 2021 | 27 Jan 2022 | 40 | 56% | 31% | 14% | 24% |
| 01 Jan 2021 - 30 Jun 2021 | 29 Jul 2021 | 14 | 86% | 12% | 2% | 7% |
| 01 Jan 2020 - 30 Jun 2020 | 28 Jul 2020 | 45 | 43% | 30% | 27% | 18% |
| 01 Jul 2019 - 31 Dec 2019 | 29 Jan 2020 | 46 | 41% | 29% | 30% | 28% |
| 01 Jan 2019 - 30 Jun 2019 | 29 Jul 2019 | 43 | 43% | 30% | 27% | 86% |
| 01 Jul 2018 - 31 Dec 2018 | 29 Jan 2019 | 50 | 45% | 31% | 24% | 22% |
| 01 Jan 2018 - 30 Jun 2018 | 27 Jul 2018 | 44 | 43% | 32% | 25% | 20% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
Oxoid Limited’s Standard Payment Terms are Net 30 days, however, we use a variety of payment terms which are negotiated individually with the Suppliers which can vary from N90, N75, N60, N45 and N7. No early settlement terms are currently used with Oxoid Ltd’s Suppliers. All extended term contracts are agreed with the Supplier prior to execution.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
90
Should an invoice be disputed, this is queried internally by the Accounts Payable team with the Purchasing department where a purchase order is in place, or with the Cost Centre owner to resolve for non-PO items. Should this not be possible, the Supplier will be notified of the query with the aim of providing assistance to avoid late payment.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Oxoid Limited is a UK registered company that forms part of the Thermo Fisher Scientific group, a global science and technology group that describes itself as enabling customers to make the world healthier, cleaner and safer, delivering technology, pharmaceutical and biotechnology services. The group's offering spans laboratory equipment, reagents, contract development and manufacturing (CDMO), clinical research services and related scientific support. Oxoid Limited's own registered activity is classified as other manufacturing not elsewhere classified. The company is active, was incorporated in December 1996, and is registered in Altrincham, Cheshire, operating as a UK entity within the wider Thermo Fisher Scientific corporate structure rather than as an independently trading business.
Generated from the company's website and Companies House records. Sources: thermofisher.com